Cargando…
Effect of CYP2D6 polymorphisms on plasma concentration and therapeutic effect of risperidone
BACKGROUND: This study aimed to investigate the influence of CYP2D6 polymorphisms on risperidone plasma concentrations in patients with schizophrenia. Based on pharmacogenomics, we examined whether plasma concentration of risperidone is associated with clinical response and adverse side-effects. MET...
Autores principales: | Lu, Jinjun, Yang, Ye, Lu, Jian, Wang, Zuqing, He, Yiping, Yan, Yeliang, Fu, Kai, Jiang, Wenjuan, Xu, Yunqing, Wu, Renrong, Liu, Wenqing, Zhao, Jingping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7856706/ https://www.ncbi.nlm.nih.gov/pubmed/33535976 http://dx.doi.org/10.1186/s12888-020-03034-9 |
Ejemplares similares
-
CYP2D6 polymorphisms and their influence on risperidone treatment
por: Puangpetch, Apichaya, et al.
Publicado: (2016) -
Association between olanzapine concentration and metabolic dysfunction in drug-naive and chronic patients: similarities and differences
por: Kang, Dongyu, et al.
Publicado: (2022) -
Determination of Plasma Concentration Reference Ranges for Risperidone and Paliperidone
por: Korell, J, et al.
Publicado: (2017) -
C677T Polymorphism in the MTHFR Gene Is Associated With Risperidone-Induced Weight Gain in Schizophrenia
por: Liao, Jingping, et al.
Publicado: (2020) -
A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia
por: Chavan, Bir S., et al.
Publicado: (2018)